Plante Moran Financial Advisors »

Adaptimmune Therapeutics shares owned by Plante Moran Financial Advisors

Quarter-by-quarter ownership of Adaptimmune Therapeutics (ADAP) shares owned by Plante Moran Financial Advisors from 13F filings

Historical chart of Plante Moran Financial Advisors investment in Adaptimmune Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Adaptimmune Therapeutics held by Plante Moran Financial Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adaptimmune Therapeutics by Plante Moran Financial Advisors

Quarter filed Position value Share count Share price at filing
2025-06-30 $222 925 0.24
2025-03-31 $182 925 0.20
2024-12-31 $498 925 0.54
2024-09-30 $879 925 0.95

More positions owned by Plante Moran Financial Advisors

Vanguard S&p 500 Etf Etf (VOO)
Vanguard Extended Market Etf Etf (VXF)
Vanguard Ftse Developed Markets Etf Etf (VEA)
Vanguard Large-cap Etf Etf (VV)
Ishares National Muni Bond Etf Etf (MUB)
Vanguard Small Cap Value Etf Etf (VBR)
Spdr S&p 500 Etf Trust Etf (SPY)
Schwab U.s. Mid-cap Etf Etf (SCHM)
Spdr Portfolio Developed World Ex-us Etf Etf (SPDW)
Apple Stock (AAPL)
Ishares Core S&p 500 Etf Etf (IVV)
Microsoft Corp Stock (MSFT)
Vanguard Total Stock Market Etf Etf (VTI)
Amazon Stock (AMZN)
Vanguard Growth Etf Etf (VUG)

View all positions for Plante Moran Financial Advisors

Top funds holding Adaptimmune Therapeutics

Long Focus Capital Management
UBS Group
Morgan Stanley
Renaissance Technologies
Jane Street
Acadian Asset Management
Empirical Finance
National Asset Management
Rathbones Brothers
FMR
Susquehanna International
Citadel Advisors
Lumbard Investment Counseling
Lakeridge Wealth Management
XTX Topco

View all funds holding Adaptimmune Therapeutics